Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : GTIS - Will it be a Phoenix or not ? -- Ignore unavailable to you. Want to Upgrade?

To: Scot who wrote (2191)	4/12/1999 12:07:00 PM
From: RJC2006	Respond to of 2319

I don't know about Prey but Duke really doesn't need an E3 presence to sell. Can't argue with the article. What since Unreal has GT shipped that has been anything near mid-quality? I noticed that 'Nam is already in the bargain bin at E3. Blow Bambi's Brains Out still has a plethora of expansions out and they all sell with a margin so low it hardly adds to the bottom line I suspect. Nevertheless, any hot selling trademark is susceptible to marketing myopia, the idea that you can keep selling the same thing and only enhance the technology is a sure loser in the long run.

To: Scot who wrote (2191)	4/12/1999 12:57:00 PM
From: Scott Miller	Respond to of 2319

>>> Here is an interesting little article....and some news that DNF will not be demoed at E3. I wonder if Scott has any comment on this: It's true, we're not going to show our games at E3, including Max Payne (a Gathering of Developers game). The reason is simple: These games are not close to release yet, and therefore E3 will be a huge distraction if we were to make a demo (which takes away from real development work) and send key personnel there to demo the games. E3 can easily set back development a full month, and we do not think that's worth it--we'd rather get the game out a month sooner. Plus, a game like Duke has all the hype it needs. There's no need to over hype a game this well anticipated.